US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020
Nadine Shehab, Chief Scientist, co-authored this CDC report which quantifies changes in outpatient prescriptions of hydroxychloroquine, chloroquine, and azithromycin during the COVID-19 pandemic.